Abiopharma

Shareholder Alert: Ademi LLP investigates whether MarineMax, Inc. is obtaining a Fair Price for Public Shareholders

Form 8.3

LINDIAN ACQUIERT LES 49 % RESTANTS POUR DÉTENIR 100 % DE LUSINE HYDROMÉTALLURGIQUE EN ACTIVITÉ DE SARECO

BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates

J.B. Hunt Celebrates 65 Years of Moving Freight Forward

Advance notice of intention to convene an annual general meeting

Form 8.3

BeOne Medicines et Revolution Medicines annoncent un accord de collaboration portant sur le développement clinique et la commercialisation régionale

Total Voting Rights and Transaction in Own Shares

WEC Energy Groups 2025 Corporate Responsibility Report highlights reliability, sustainability and long-term value